The HER2-low revolution in breast oncology: steps forward and emerging challenges by Eleonora Nicolò, Luca Boscolo Bielo, Giuseppe Curigliano, Paolo Tarantino

Get full text

Cancer in a drop: Liquid biopsy highlights from San Antonio Breast Cancer Symposium (SABCS) 2024 by Letizia Pontolillo, Mohamed A. Gouda, Konstantinos Venetis, Eleonora Nicolò, Carolina Reduzzi

Get full text

Cellular residual disease (CRD) in early breast cancer –Expanding the concept of minimal residual disease monitoring? by Mara S. Serafini, Elisabetta Molteni, Eleonora Nicolò, Lorenzo Gerratana, Carolina Reduzzi, Massimo Cristofanilli

Get full text

Real-time assessment of HER2 status in circulating tumor cells of breast cancer patients: Methods of detection and clinical implications by Eleonora Nicolò, Mara Serena Serafini, Laura Munoz-Arcos, Letizia Pontolillo, Elisabetta Molteni, Nadia Bayou, Eleni Andreopoulou, Giuseppe Curigliano, Carolina Reduzzi, Massimo Cristofanilli

Get full text

The role of liquid biopsy as a catalyst for sustained progress in precision oncology – Perspective of the young committee of the international society of liquid biopsy by Erick F. Saldanha, Eleonora Nicolo, Konstantinos Venetis, Diego de Miguel-Perez, Ana Ortega-Franco, Angelo Dipasquale, Mohamed A. Gouda, Surbhi Singhal, George Adigbli, Carolina Reduzzi

Get full text

530 Clinicopathologic features and outcome of patients with microsatellite instable (MSI-H) cancer treated in a Phase I unit by Carmen Criscitiello, Giuseppe Curigliano, Stefania Morganti, Gloria Pellizzari, Paolo Tarantino, Carmen Belli, Edoardo Crimini, Matteo Repetto, Angela Esposito, Marzia Locatelli, Ida Minchella, Eleonora Nicolo’, Luca Boscolo Bielo, Grazia Castellano, Pier Paolo Maria Berton Giachetti, Gabriele Antonarelli, Liliana Ascione, Carmine Valenza, Beatrice Taurelli Salimbeni